Various PET radiopharmaceuticals are used for different medical imaging purposes. F-18 FDG is commonly employed to assess abnormal glucose metabolism, particularly in brain imaging related to epileptic seizures, oncology for suspected cancer, and cardiac viability for conditions like coronary artery disease and left ventricular dysfunction.